CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies
- 1 March 2001
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 8 (3), 273-278
- https://doi.org/10.1038/sj.cdd.4400813
Abstract
In recent years, some studies on the expression of CD95(Fas/APO-1) ligand (CD95L) in tissues or cells raised concerns about the specificity of the antibodies used. We therefore tested 12 CD95L antibodies for their reliability in immunocyto/histochemistry by (i) staining CD95L-transfected and control CV-1/EBNA cells and (ii) comparing staining patterns in immunohistochemically labeled tissue sections with the localization of CD95L+ cells in in situ hybridization. While G247-4, NOK-1, NOK-2, 4H9, and MIKE-1 stained CD95L-transfected cells and did not significantly bind to controls, G247-4 was the only antibody giving satisfying signals in tissue sections perfectly matching the distribution of CD95L+ cells by in situ hybridization. MAb 33, C-20, and N-20 comparably stained both transfected and control cells and showed considerable background or falsely positive staining in sections. MIKE-2, 8B8, A11, and 4A5 did not or only very faintly bind to either cells and, thus, were not tested on sections. We conclude that G247-4 is the only tested antibody that is recommendable for immunohistochemistry. Cell Death and Differentiation (2001) 8, 273–278Keywords
This publication has 16 references indexed in Scilit:
- Antibody mAb33 from transduction laboratories detects human CD95L in ELISA but not in immunoblots.Cell Death & Differentiation, 2000
- mAb 33 from Transduction Laboratories specifically binds to human CD95-LCell Death & Differentiation, 2000
- Specificity questions concerning the clone 33 anti-fas ligand antibodyCell Death & Differentiation, 2000
- The Fas counterattack: cancer as a site of immune privilegeImmunology Today, 1999
- CD95 Ligand (CD95L) in Normal Human Lymphoid TissuesThe American Journal of Pathology, 1999
- Constitutive Expression of FasL in ThyrocytesScience, 1998
- TRAIL-R2: a novel apoptosis-mediating receptor for TRAILThe EMBO Journal, 1997
- Role of Fas-mediated cell death in the regulation of immune responsesCurrent Opinion in Immunology, 1996
- Human Fas ligand: gene structure, chromosomal location and species specificityInternational Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993